Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Schäfer M, Meißner Y, Kekow J, Berger S, Remstedt S, Manger B, Listing J, Strangfeld A, Zink A.

Rheumatology (Oxford). 2019 Nov 20. pii: kez535. doi: 10.1093/rheumatology/kez535. [Epub ahead of print]

PMID:
31745566
2.

[Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?]

Knitza J, Kleyer A, Schett G, Manger B.

Orthopade. 2019 Nov;48(11):949-956. doi: 10.1007/s00132-019-03805-7. Review. German.

PMID:
31515589
3.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Nov;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. Epub 2019 Sep 9.

PMID:
31501138
4.

Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological Perspective.

Leavis H, Zwerina J, Manger B, Fritsch-Stork RDE.

Curr Rheumatol Rep. 2019 Sep 5;21(10):55. doi: 10.1007/s11926-019-0854-5. Review.

PMID:
31486986
5.

Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.

Ellmann H, Bayat S, Araujo E, Manger B, Kleyer A, Cavallaro A, Lell M, Schenker H, Simon D, Tascilar K, Baraf HSB, Schett G, Rech J.

Arthritis Rheumatol. 2020 Jan;72(1):150-156. doi: 10.1002/art.41063. Epub 2019 Dec 10.

PMID:
31353871
6.

Calcium pyrophosphate deposition disease induced inflammatory back pain.

Kleyer A, Knitza J, Schett G, Manger B.

Rheumatology (Oxford). 2020 Feb 1;59(2):456. doi: 10.1093/rheumatology/kez225. No abstract available.

PMID:
31209476
7.

Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.

Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J.

J Rheumatol. 2019 May;46(5):460-466. doi: 10.3899/jrheum.180028. Epub 2018 Dec 1.

PMID:
30504510
8.

[Depression as comorbidity of rheumatoid arthritis].

Baerwald C, Manger B, Hueber A.

Z Rheumatol. 2019 Apr;78(3):243-248. doi: 10.1007/s00393-018-0568-5. Review. German.

PMID:
30488094
9.

[Erdheim-Chester disease : An important differential diagnosis and its main symptoms].

Knitza J, Kampylafka E, Wacker J, Schett G, Manger B.

Z Rheumatol. 2019 Feb;78(1):66-71. doi: 10.1007/s00393-018-0566-7. Review. German.

PMID:
30430236
10.

Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS.

Sauer EM, Schliep S, Manger B, Lee DH, Linker RA.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 10;5(5):e488. doi: 10.1212/NXI.0000000000000488. eCollection 2018 Sep. No abstract available.

11.

Unilateral plantar erythema nodosum in sarcoidosis.

Hueber AJ, Schett G, Manger B.

Arthritis Rheumatol. 2018 Feb;70(2):297. doi: 10.1002/art.40341. Epub 2018 Jan 5. No abstract available.

12.

Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.

Fischer S, Rath T, Geppert CI, Manger B, Schett G, Neurath MF, Atreya R.

Am J Gastroenterol. 2017 Oct;112(10):1621-1623. doi: 10.1038/ajg.2017.242. No abstract available.

PMID:
28978957
13.

Hard palate hyperpigmentation-a rare side effect of antimalarials.

Manger K, von Streitberg U, Seitz G, Kleyer A, Manger B.

Arthritis Rheumatol. 2018 Jan;70(1):152. doi: 10.1002/art.40327. Epub 2017 Nov 28. No abstract available.

14.

The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.

Schönau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, Kuwert T, Schett G.

Ann Rheum Dis. 2018 Jan;77(1):70-77. doi: 10.1136/annrheumdis-2017-211687. Epub 2017 Sep 19.

PMID:
28928271
15.

Pancreatic Panniculitis and Polyarthritis.

Zundler S, Strobel D, Manger B, Neurath MF, Wildner D.

Curr Rheumatol Rep. 2017 Aug 26;19(10):62. doi: 10.1007/s11926-017-0690-4. Review.

PMID:
28844095
16.

Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity.

Manger B, Schett G.

Clin Immunol. 2018 Jan;186:67-70. doi: 10.1016/j.clim.2017.07.021. Epub 2017 Jul 21. Review.

PMID:
28736272
17.

Aortic dissection and fever: cause or consequence.

Manger B, Schett G.

Z Rheumatol. 2017 Aug;76(6):550-551. doi: 10.1007/s00393-017-0316-2. No abstract available.

PMID:
28523510
18.

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.

Meissner Y, Richter A, Manger B, Tony HP, Wilden E, Listing J, Zink A, Strangfeld A.

Ann Rheum Dis. 2017 Sep;76(9):1583-1590. doi: 10.1136/annrheumdis-2017-211209. Epub 2017 May 8.

19.

Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.

Braun J, Krüger K, Manger B, Schneider M, Specker C, Trappe HJ.

Dtsch Arztebl Int. 2017 Mar 24;114(12):197-203. doi: 10.3238/arztebl.2017.0197. Review.

20.

Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damage.

Kleyer A, Beyer L, Simon C, Stemmler F, Englbrecht M, Beyer C, Rech J, Manger B, Krönke G, Schett G, Hueber AJ.

Arthritis Res Ther. 2017 Feb 10;19(1):34. doi: 10.1186/s13075-017-1234-z.

21.

[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche AK, Braun J.

Z Rheumatol. 2017 Mar;76(2):118-124. doi: 10.1007/s00393-016-0249-1. Review. German.

PMID:
28078432
22.

Fever of unknown origin, giant cell arteritis, and aortic dissection.

Hofheinz K, Bertz S, Wacker J, Schett G, Manger B.

Z Rheumatol. 2017 Feb;76(1):83-86. doi: 10.1007/s00393-016-0245-5.

PMID:
28074266
23.

Imaging of gout: New tools and biomarkers?

Araujo EG, Manger B, Perez-Ruiz F, Thiele RG.

Best Pract Res Clin Rheumatol. 2016 Aug;30(4):638-652. doi: 10.1016/j.berh.2016.10.010. Epub 2016 Nov 12. Review.

PMID:
27931959
24.

Gout mimicking rheumatoid arthritis.

Petsch C, Araujo E, Hueber A, Schett G, Manger B, Rech J.

Semin Arthritis Rheum. 2017 Feb;46(4):e15. doi: 10.1016/j.semarthrit.2016.08.003. Epub 2016 Aug 16. No abstract available.

PMID:
27660106
25.

Elevated serum levels of free interleukin-18 in adult-onset Still's disease.

Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, Schiffrin EJ, Schett G, Manger B, Bas S, Del Val G, Gabay C.

Rheumatology (Oxford). 2016 Dec;55(12):2237-2247. Epub 2016 Sep 10.

PMID:
27616144
26.

[The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision].

Pattloch D, Richter A, Manger B, Dockhorn R, Meier L, Tony HP, Zink A, Strangfeld A.

Z Rheumatol. 2017 Apr;76(3):210-218. doi: 10.1007/s00393-016-0174-3. German.

PMID:
27518855
27.

[Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüßlein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche A, Braun J.

Z Rheumatol. 2016 Aug;75 Suppl 2:11-60. doi: 10.1007/s00393-016-0147-6. Review. German. No abstract available.

PMID:
27481119
28.

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.

Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G.

Ann Rheum Dis. 2017 Feb;76(2):399-407. doi: 10.1136/annrheumdis-2016-209297. Epub 2016 Jun 20.

PMID:
27323772
29.

[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Braun J, Krause A, Aringer M, Burmester G, Bessler F, Engel JM, Faubel U, Fischer-Betz R, Genth E, Gromnica-Ihle E, Hellmich B, Kötter I, Krüger K, Lakomek J, Lorenz HM, Manger B, Märker-Hermann E, Minden K, Müller-Ladner U, Rautenstrauch J, Rehart S, Riemekasten G, Rudwaleit M, Rüther W, Schett G, Schuch F, Schulze-Koops H, Specker C, Wassenberg S, Wiek D, Zink A, Schneider M.

Z Rheumatol. 2016 May;75(4):416-28. doi: 10.1007/s00393-016-0059-5. German.

PMID:
27138788
30.

[Allopurinol is positively associated with cardiovascular health].

Manger B.

Dtsch Med Wochenschr. 2016 Apr;141(9):598. doi: 10.1055/s-0042-103368. Epub 2016 Apr 28. German. No abstract available.

PMID:
27123719
31.

[Rare rheumatic diseases].

Manger B, Swoboda B.

Z Rheumatol. 2016 Mar;75(2):133. doi: 10.1007/s00393-016-0055-9. German. No abstract available.

PMID:
26838519
32.

[Scurvy. A rare differential diagnosis of rheumatic diseases].

Hofheinz K, Ganzleben I, Schliep S, Wacker J, Schett G, Manger B.

Z Rheumatol. 2016 Mar;75(2):166-72. doi: 10.1007/s00393-015-0030-x. German.

PMID:
26783153
33.

Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia.

Petsch C, Araujo EG, Englbrecht M, Bayat S, Cavallaro A, Hueber AJ, Lell M, Schett G, Manger B, Rech J.

Semin Arthritis Rheum. 2016 Jun;45(6):663-8. doi: 10.1016/j.semarthrit.2015.11.014. Epub 2015 Dec 2.

PMID:
26743072
34.

Interleukin-1 function and role in rheumatic disease.

Schett G, Dayer JM, Manger B.

Nat Rev Rheumatol. 2016 Jan;12(1):14-24. doi: 10.1038/nrrheum.2016.166. Epub 2015 Dec 10. Review.

PMID:
26656658
35.

Adult onset Still's disease associated with malignancy-Cause or coincidence?

Hofheinz K, Schett G, Manger B.

Semin Arthritis Rheum. 2016 Apr;45(5):621-6. doi: 10.1016/j.semarthrit.2015.10.003. Epub 2015 Oct 22. Review.

PMID:
26581485
36.

Tophus resolution with pegloticase: a prospective dual-energy CT study.

Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A, Hueber AJ, Cavallaro A, Lell M, Dalbeth N, Manger B, Schett G, Rech J.

RMD Open. 2015 Jun 17;1(1):e000075. doi: 10.1136/rmdopen-2015-000075. eCollection 2015.

37.

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G.

Ann Rheum Dis. 2016 Sep;75(9):1637-44. doi: 10.1136/annrheumdis-2015-207900. Epub 2015 Oct 19.

38.

Development of a Dual-Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout.

Bayat S, Aati O, Rech J, Sapsford M, Cavallaro A, Lell M, Araujo E, Petsch C, Stamp LK, Schett G, Manger B, Dalbeth N.

Arthritis Care Res (Hoboken). 2016 Jun;68(6):769-75. doi: 10.1002/acr.22754.

39.

Bilateral Orbital IgG4-Related Disease with Systemic and Corneal Involvement Showing an Excellent Response to Steroid and Rituximab Therapy: Report of a Case with 11 Years Follow-Up.

Berta AI, Agaimy A, Braun JM, Manger B, Kruse FE, Holbach L.

Orbit. 2015;34(5):299-301. doi: 10.3109/01676830.2015.1057290. Epub 2015 Aug 18.

PMID:
26362833
40.

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study.

Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A.

Clin Exp Gastroenterol. 2015 Jul 21;8:205-13. doi: 10.2147/CEG.S81922. eCollection 2015.

41.

How neutrophil extracellular traps orchestrate the local immune response in gout.

Maueröder C, Kienhöfer D, Hahn J, Schauer C, Manger B, Schett G, Herrmann M, Hoffmann MH.

J Mol Med (Berl). 2015 Jul;93(7):727-34. doi: 10.1007/s00109-015-1295-x. Epub 2015 May 24. Review.

PMID:
26002146
42.

[Uricosuric agent benzbromarone vs. allopurinol: comparable effect].

Manger B.

Dtsch Med Wochenschr. 2015 Apr;140(8):562. doi: 10.1055/s-0041-101396. Epub 2015 Apr 16. German. No abstract available.

PMID:
25945905
43.

Rheumatic manifestations of scurvy.

Ferrari C, Possemato N, Pipitone N, Manger B, Salvarani C.

Curr Rheumatol Rep. 2015 Apr;17(4):26. doi: 10.1007/s11926-015-0503-6. Review.

PMID:
25854491
44.

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J.

Ann Rheum Dis. 2016 Jan;75(1):45-51. doi: 10.1136/annrheumdis-2014-206439. Epub 2015 Feb 6.

PMID:
25660991
45.

Paraneoplastic syndromes in rheumatology.

Manger B, Schett G.

Nat Rev Rheumatol. 2014 Nov;10(11):662-70. doi: 10.1038/nrrheum.2014.138. Epub 2014 Aug 19. Review.

PMID:
25136782
46.

Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines.

Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, Lell M, Manger B, Rech J, Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, Herrmann M.

Nat Med. 2014 May;20(5):511-7. doi: 10.1038/nm.3547. Epub 2014 Apr 28.

PMID:
24784231
47.

Palmar fasciitis and polyarthritis syndrome-systematic literature review of 100 cases.

Manger B, Schett G.

Semin Arthritis Rheum. 2014 Aug;44(1):105-11. doi: 10.1016/j.semarthrit.2014.03.005. Epub 2014 Mar 6. Review.

PMID:
24684975
48.

[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].

Tarner IH, Albrecht K, Fleck M, Gromnica-Ihle E, Keyßer G, Köhler L, Kötter I, Krüger K, Kuipers J, Nüßlein H, Rubbert-Roth A, Wollenhaupt J, Schneider M, Manger B, Müller-Ladner U; internationalen 3e-Initiative.

Z Rheumatol. 2014 May;73(4):363-73. doi: 10.1007/s00393-013-1249-z. German.

PMID:
24590079
49.

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab.

Listing J, Kekow J, Manger B, Burmester GR, Pattloch D, Zink A, Strangfeld A.

Ann Rheum Dis. 2015 Feb;74(2):415-21. doi: 10.1136/annrheumdis-2013-204021. Epub 2013 Nov 29.

50.

[New aspects on the pathogenesis of psoriatic arthritis].

Hueber AJ, Manger B.

Z Rheumatol. 2013 Oct;72(8):758-63. doi: 10.1007/s00393-013-1186-x. German.

PMID:
24046231

Supplemental Content

Loading ...
Support Center